Enveric Biosciences (ENVB) Shares Outstanding (Entity) (2010 - 2026)
Enveric Biosciences (ENVB) reported Shares Outstanding (Entity) of 3.94 million for Q2 2026, compared with 252,159 a year earlier and up 160.6% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
For FY2025, Enveric Biosciences posted Shares Outstanding (Entity) of 334,719, up 698.7% from FY2024.
- Shares Outstanding (Entity) has increased for three consecutive years, with a five-year compound annual growth rate of 60.0% (FY2020 to FY2025).
- By year, Shares Outstanding (Entity) came in at 41,907 in FY2024 (+249.4%), 11,995 in FY2023 (+49.3%), 8,033 in FY2022 (-93.9%) and 131,207 in FY2021 (+310.5%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2010.
- The high point for year-over-year Shares Outstanding (Entity) in five years was Q1 2026 (growth of 908.2%); the low point was Q1 2023 (a decline of 95.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 1.51 million (Q1 2026), 334,719 (Q4 2025) and 313,242 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | 3.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.94 Mn |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 334,719.00 |
| Sep 30, 2025 | 313,242.00 |
| Jun 30, 2025 | 252,159.00 |
| Mar 31, 2025 | 149,809.00 |
| Dec 31, 2024 | 41,907.00 |
| Sep 30, 2024 | 49,972.00 |
| Jun 30, 2024 | 43,770.00 |
| Mar 31, 2024 | 22,231.00 |
| Dec 31, 2023 | 11,995.00 |
| Sep 30, 2023 | 12,122.00 |
| Jun 30, 2023 | 11,899.00 |
| Mar 31, 2023 | 11,546.00 |
| Dec 31, 2022 | 8,033.00 |
| Sep 30, 2022 | 11,546.00 |
| Jun 30, 2022 | 5,854.00 |
| Mar 31, 2022 | 235,318.00 |
| Dec 31, 2021 | 131,207.00 |
| Sep 30, 2021 | 128,572.00 |
API Access
Enveric Biosciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();